Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat for Prevention of Acute Kidney Injury After CABG
NCT05010460Phase 2Terminated
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2021
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roxadustat in acute kidney injury (AKI), sponsored by Peking Union Medical College Hospital. Started Sep 2021; status: terminated.
02
Drugs
roxadustat
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05010460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05010460.